Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. | 1,226,607 | reported | 02 Mar 2026 | tx 35+2,582,321−647,219 |
| Iterum Therapeutics plc | 18,839 | reported | 15 Jun 2023 | tx 9+342,528−60,293 |
| Rosewind CORP | 9,052 | reported | 08 Apr 2021 | tx 1+6,500 |
| Neos Therapeutics, Inc. | 0 | reported | 19 Mar 2021 | tx 12+138,715−138,715 |
| XERIS PHARMACEUTICALS INC | 0 | reported | 05 Oct 2021 | tx 17+393,314−488,866 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | SALE | Xeris Biopharma Holdings, Inc. | 16,567 | 6.24 USD | |
| 02 Mar 2026 | SALE | Xeris Biopharma Holdings, Inc. | 100 | 7.06 USD | |
| 02 Feb 2026 | SALE | Xeris Biopharma Holdings, Inc. | 16,667 | 7.45 USD | |
| 31 Jan 2026 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 46,914 | 7.36 USD | |
| 31 Jan 2026 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 24,266 | 7.36 USD | |
| 30 Jan 2026 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 121,293 | 0.00 USD | |
| 31 Jan 2026 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 98,375 | 7.36 USD | |
| 30 Jan 2026 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 162,162 | 0.00 USD | deriv |
| 02 Jan 2026 | SALE | Xeris Biopharma Holdings, Inc. | 16,667 | 7.43 USD | |
| 01 Dec 2025 | SALE | Xeris Biopharma Holdings, Inc. | 16,667 | 7.01 USD | |
| 11 Nov 2025 | SALE | Xeris Biopharma Holdings, Inc. | 16,667 | 7.40 USD | |
| 20 Mar 2025 | SALE | Xeris Biopharma Holdings, Inc. | 40,000 | 5.43 USD | |
| 31 Jan 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 98,375 | 3.56 USD | |
| 31 Jan 2025 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 185,000 | 0.00 USD | |
| 31 Jan 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 45,909 | 3.56 USD | |
| 31 Jan 2025 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 300,000 | 0.00 USD | deriv |
| 03 Jan 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 32,039 | 3.61 USD | |
| 29 Jan 2022 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 14,037 | 2.11 USD | |
| 31 Jan 2024 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 45,909 | 2.46 USD | |
| 29 Jan 2024 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 19,675 | 2.66 USD | |
| 03 Jan 2024 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 33,488 | 2.24 USD | |
| 31 Jan 2023 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 5,784 | 1.24 USD | |
| 29 Jan 2023 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 21,177 | 1.26 USD | |
| 03 Jan 2023 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 33,488 | 1.12 USD | |
| 31 Jan 2022 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 4,448 | 2.11 USD |
1 purchase reported after at least 12 months of silence — most recent on 19 Feb 2019.